LEUKEMIA, LYMPHOCYTIC, ACUTE
Clinical trials for LEUKEMIA, LYMPHOCYTIC, ACUTE explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, LYMPHOCYTIC, ACUTE trials appear
Sign up with your email to follow new studies for LEUKEMIA, LYMPHOCYTIC, ACUTE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharging immune cells to fight blood cancer
Disease control Recruiting nowThis study tests a new treatment for people with certain blood cancers, like leukemia. Doctors take a patient's own immune cells, modify them in a lab to recognize unique markers on their cancer cells, and then give them back. The goal is to see if this personalized therapy is sa…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, ACUTE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New hope for leukemia: experimental drug enzomenib enters human trials
Disease control Recruiting nowThis study tests an experimental drug called enzomenib in about 600 people with acute leukemia and certain other blood cancers. The goal is to find the safest dose and see if the drug can shrink or control the cancer. Participants must have cancers that came back or did not respo…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, ACUTE
Phase: PHASE1, PHASE2 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC